Can-C

The effect of the compound, N-acetylcarnosine,drops are not suitable for topical application to the
on human cataracts has been thoroughlyeye.
investigated and proven to be safe and effectiveCan-C™ eye drops with N-acetylcarnosine
toward slowing down and even reversing theare not only effective in the treatment of
disease.cataract but have been shown to be beneficial for
Over the last ten years, Dr. Mark Babizhayev andother eye problems such as open-angle primary
his team of Russian medical researchers haveglaucoma, computer vision syndrome, dry eye
continued to observe the ongoing beneficialsyndrome, retinal disease, complications of
effects of this breakthrough cataract eye drop. Indiabetes mellitus and other systemic diseases, etc.
clinical trials conducted, it showed that patientsCan-C™ has been reported to have virtually
instilled with two drops of the 1%no negative side effects however when using
N-acetylcarnosine (Can-C™) eye drops twiceother eye medications it is always recommended
daily for a period of 6 months showed vastto consult first with your eye care specialist.
improvement in their pre-existing eye conditions.With the release of the Can-C™ product into
The effective rate was a reported 100%. Thesethe market supported by the clinical study results,
results led to the patent and manufacture of thevarious medical and pharmaceutical companies
product providing a long awaited, safe andquickly released copycat cataract eye drop
effective alternative to cataract surgery.solutions containing N-acetylcarnosine. Dr. Mark
How do Can-C™ eye drops actually reverseBabizhayev the senior research investigator with
cataracts? This eye drop with a proprietary formInnovative Vision Products cautions consumers to
of N-acetylcarnosine acts as a carrier for thebe wary of these random formulations. The
di-peptide, carnosine. Carnosine which is naturallysuccessful clinical results were dependent upon a
present throughout the human body decreases inhighly specific purity factor of the raw material
level as each person advances in age whichitself or rather, the precise content of the
contibutes to the onset of age-related problemstransition metal ion traces. This patent protected
such as cataract. Carnosine is both a knownrefinement of the Can-C™ N-acetylcarnosine
antioxidant and glycation inhibitor. When it comesraw material, with a Japanese chemical company,
to ocular disease such as cataract, eye drops areis what ultimately resulted in the anti-cataract
the most direct delivery route to the source ofsuccesses achieved and long term safety. It is
the problem, which is the ocular lens. In the formonly this proprietary form of N-acetylcarnosine
of N-acetyl-carnosine, this normally insoluble lipid,raw material that will ever be used in
carnosine, becomes lipid soluble thus gainingCan-C™ and this purity factor remains
entrance into the lipid membrane of both theproprietary to Innovative Vision Products.
corneal and lens cells. This bioavailability ofFortunately there is a simple way for consumers
N-acetylcarnosine at the cellular level and itsto verify if they have purchased the clinically
ultimate release of the carnosine molecule is whatproven formula patented by Innovative Vision
results in the reported beneficial effects on theProducts as the following statement is printed on
eye.each and every box, "Approved by Innovative
What is the difference between N-acetylcarnosineVision Products.” To obtain the desired
and L-carnosine? Firstly, studies show that onlylong-term efficacy and safety of this eye drops
N-acetylcarnosine is clinically proven to be suitablebe sure to purchase Can-C™ and be sure to
for eye use. Unfortunately L-carnosine whenlook for this statement on the side panel of the
administered topically on its own is destroyed bybox "Approved by Innovative Vision Products
the enzyme, carnosinase, a dipeptidase present in(IVP)”.
blood plasma. Due to this, simple L-carnosine eye